These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21829172)

  • 81. Physiological regulation of the pancreatic {beta}-cell: functional insights for understanding and therapy of diabetes.
    McClenaghan NH
    Exp Physiol; 2007 May; 92(3):481-96. PubMed ID: 17272356
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols.
    Liew CG
    Rev Diabet Stud; 2010; 7(2):82-92. PubMed ID: 21060967
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pdx1 and Ngn3 overexpression enhances pancreatic differentiation of mouse ES cell-derived endoderm population.
    Kubo A; Stull R; Takeuchi M; Bonham K; Gouon-Evans V; Sho M; Iwano M; Saito Y; Keller G; Snodgrass R
    PLoS One; 2011; 6(9):e24058. PubMed ID: 21931641
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors.
    McGaugh EC; Nostro MC
    J Vis Exp; 2017 Mar; (121):. PubMed ID: 28362406
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Stem cells and the endocrine pancreas.
    Wu Y; Persaud SJ; Jones PM
    Br Med Bull; 2011; 100():123-35. PubMed ID: 21642368
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Glucose-responsive insulin-producing cells from stem cells.
    Kaczorowski DJ; Patterson ES; Jastromb WE; Shamblott MJ
    Diabetes Metab Res Rev; 2002; 18(6):442-50. PubMed ID: 12469358
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Regeneration of insulin-producing islets from dental pulp stem cells using a 3D culture system.
    Yagi Mendoza H; Yokoyama T; Tanaka T; Ii H; Yaegaki K
    Regen Med; 2018 Sep; 13(6):673-687. PubMed ID: 30028236
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.
    Montgomery A; Wong A; Gabers N; Willerth SM
    Biomater Sci; 2015 Feb; 3(2):401-13. PubMed ID: 26218131
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Translational embryology: using embryonic principles to generate pancreatic endocrine cells from embryonic stem cells.
    Spence JR; Wells JM
    Dev Dyn; 2007 Dec; 236(12):3218-27. PubMed ID: 17973329
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Generation of Insulin-Producing Cells From Human-Induced Pluripotent Stem Cells Using a Stepwise Differentiation Protocol Optimized With Platelet-Rich Plasma.
    Enderami SE; Mortazavi Y; Soleimani M; Nadri S; Biglari A; Mansour RN
    J Cell Physiol; 2017 Oct; 232(10):2878-2886. PubMed ID: 27925205
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Current status of regeneration of pancreatic β-cells.
    Minami K; Seino S
    J Diabetes Investig; 2013 Mar; 4(2):131-41. PubMed ID: 24843642
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pluripotent stem cells as a potential tool for disease modelling and cell therapy in diabetes.
    Abdelalim EM; Bonnefond A; Bennaceur-Griscelli A; Froguel P
    Stem Cell Rev Rep; 2014 Jun; 10(3):327-37. PubMed ID: 24577791
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Stem cell approaches for diabetes: towards beta cell replacement.
    Weir GC; Cavelti-Weder C; Bonner-Weir S
    Genome Med; 2011 Sep; 3(9):61. PubMed ID: 21951399
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Clinical review: The emerging cell biology of thyroid stem cells.
    Davies TF; Latif R; Minsky NC; Ma R
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2692-702. PubMed ID: 21778219
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Harnessing gut cells for functional insulin production: Strategies and challenges.
    Baafi K; March JC
    Biotechnol Notes; 2023; 4():7-13. PubMed ID: 39416909
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Generation of a fluorescent mNeonGreen insulin reporter line in the H1 (WA01) hESC background.
    Leavens KF; Osorio-Quintero C; Yeuteuh EA; Perez-Profeta FT; Dattoli AA; Cardenas-Diaz FL; French DL; Gadue P
    Stem Cell Res; 2024 Sep; 81():103559. PubMed ID: 39276530
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Reprogramming-Evolving Path to Functional Surrogate β-Cells.
    Kalo E; Read S; Ahlenstiel G
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139388
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Notch1 Has an Important Role in β-Cell Mass Determination and Development of Diabetes.
    Eom YS; Gwon AR; Kwak KM; Youn JY; Park H; Kim KW; Kim BJ
    Diabetes Metab J; 2021 Jan; 45(1):86-96. PubMed ID: 32174059
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Chemically defined and xenogeneic-free differentiation of human pluripotent stem cells into definitive endoderm in 3D culture.
    Diekmann U; Wolling H; Dettmer R; Niwolik I; Naujok O; Buettner FFR
    Sci Rep; 2019 Jan; 9(1):996. PubMed ID: 30700818
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Establishment of Insulin-Producing Cells From Human Embryonic Stem Cells Underhypoxic Condition for Cell Based Therapy.
    Rattananinsruang P; Dechsukhum C; Leeanansaksiri W
    Front Cell Dev Biol; 2018; 6():49. PubMed ID: 29868580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.